These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11982797)
1. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway. Chen ST; Chuang JI; Hong MH; Li EI J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. Han J; Cheng FC; Yang Z; Dryhurst G J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216 [TBL] [Abstract][Full Text] [Related]
3. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP Hung KC; Huang HJ; Wang YT; Lin AM J Ethnopharmacol; 2016 Dec; 194():522-529. PubMed ID: 27742410 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of zinc and iron augmented oxidative injuries in the nigrostriatal dopaminergic system of SD rats. Lin AM Free Radic Biol Med; 2001 Feb; 30(3):225-31. PubMed ID: 11165868 [TBL] [Abstract][Full Text] [Related]
5. Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP(+) treatment in human astrocytoma U373MG cells. Chuang JI; Chen TH J Pineal Res; 2004 Mar; 36(2):117-25. PubMed ID: 14962063 [TBL] [Abstract][Full Text] [Related]
6. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. Thomas B; Mohanakumar KP J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127 [TBL] [Abstract][Full Text] [Related]
7. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro. Huang JY; Hong YT; Chuang JI J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551 [TBL] [Abstract][Full Text] [Related]
9. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
11. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Jin BK; Shin DY; Jeong MY; Gwag MR; Baik HW; Yoon KS; Cho YH; Joo WS; Kim YS; Baik HH Neurosci Lett; 1998 Apr; 245(2):61-4. PubMed ID: 9605485 [TBL] [Abstract][Full Text] [Related]
12. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
13. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats. Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941 [TBL] [Abstract][Full Text] [Related]
14. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum. Nakai M; Mori A; Watanabe A; Mitsumoto Y Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872 [TBL] [Abstract][Full Text] [Related]
15. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease. Carriere CH; Kang NH; Niles LP Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407 [TBL] [Abstract][Full Text] [Related]
16. Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences. Banerjee R; Sreetama S; Saravanan KS; Dey SN; Mohanakumar KP Neurochem Res; 2007 Jul; 32(7):1238-47. PubMed ID: 17401660 [TBL] [Abstract][Full Text] [Related]
17. Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration. Deng Y; Jiao C; Mi C; Xu B; Li Y; Wang F; Liu W; Xu Z Mol Neurobiol; 2015 Feb; 51(1):68-88. PubMed ID: 24969583 [TBL] [Abstract][Full Text] [Related]
18. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. Andersen JK; Mo JQ; Hom DG; Lee FY; Harnish P; Hamill RW; McNeill TH J Neurochem; 1996 Nov; 67(5):2164-71. PubMed ID: 8863527 [TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. Toffa S; Kunikowska GM; Zeng BY; Jenner P; Marsden CD J Neural Transm (Vienna); 1997; 104(1):67-75. PubMed ID: 9085194 [TBL] [Abstract][Full Text] [Related]
20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]